LYRA — Lyra Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.34m
- -$15.56m
- $0.40m
NASDAQ RESUMED AT 01:27 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:22 PM
NASDAQ RESUMED AT 01:22 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:17 PM
U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
NASDAQ RESUMED AT 10:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM
NASDAQ RESUMED AT 10:19 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:14 AM
Lyra Therapeutics plunges after halting development of lead nasal drug
Brief: Lyra Therapeutics Inc - Terminates CEO Maria Palasis And CFO Jason Cavalier - SEC Filing
NASDAQ RESUMED AT 07:35 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Lyra Therapeutics Q3 net loss narrows
Brief: Lyra unveils clinical plan for LYR-210, to present late-stage sinusitis trial data
U.S. RESEARCH ROUNDUP -ANI Pharmaceuticals, Berkshire Hathaway, Chevron
Lyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Lyra Therapeutics Inc expected to post a loss of $6.02 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Estee Lauder, TC Energy, Cancer test makers